Aurobindo Pharma Ltd — Meloxicam Exporter Profile
Indian Pharmaceutical Exporter · #7 for Meloxicam · $1.1M export value · DGFT Verified
Aurobindo Pharma Ltd is the #7 Indian exporter of Meloxicam with $1.1M in export value and 127 verified shipments. Aurobindo Pharma Ltd holds a 0.6% market share in Meloxicam exports across 13 countries.
Aurobindo Pharma Ltd — Meloxicam Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Ltd Export Meloxicam?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TANZANIA | $377.6K | 26 | 33.2% |
| CANADA | $276.2K | 24 | 24.3% |
| MALTA | $168.8K | 51 | 14.9% |
| SOUTH AFRICA | $131.6K | 10 | 11.6% |
| MALAYSIA | $91.5K | 8 | 8.0% |
| IRAQ | $46.1K | 5 | 4.1% |
| ZAMBIA | $18.5K | 3 | 1.6% |
| NETHERLANDS | $6.7K | 1 | 0.6% |
| OMAN | $5.4K | 1 | 0.5% |
| QATAR | $4.8K | 2 | 0.4% |
Aurobindo Pharma Ltd exports Meloxicam to 14 countries. The largest destination is TANZANIA accounting for 33.2% of Aurobindo Pharma Ltd's Meloxicam shipments, followed by CANADA (24.3%) and MALTA (14.9%). These destinations reflect Aurobindo Pharma Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Meloxicam from Aurobindo Pharma Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| GENERICS & SPECIALITIES LTD, | TANZANIA | $180.9K | 13 |
| AURO PHARMA INC, | CANADA | $111.7K | 11 |
| AUROGEN SOUTH AFRICA (PTY) LTD, | SOUTH AFRICA | $108.9K | 8 |
| AURO PHARMA INC., | CANADA | $76.2K | 5 |
| APL SWIFT SERVICES MALTA LTD | MALTA | $75.2K | 14 |
| GENERICS SPECIALITIES LTD | TANZANIA | $61.2K | 2 |
| GENERICS & SPECIALITIES LTD | TANZANIA | $60.2K | 3 |
| UNIMED SDN BHD, | MALAYSIA | $59.5K | 5 |
| TO THE ORDER OF ABSA BANK | TANZANIA | $55.1K | 6 |
| AURO PHARMA INC., C/O LYNDEN, | CANADA | $49.5K | 2 |
Aurobindo Pharma Ltd supplies Meloxicam to 34 buyers globally. The largest buyer is GENERICS & SPECIALITIES LTD, (TANZANIA), followed by AURO PHARMA INC, (CANADA) and AUROGEN SOUTH AFRICA (PTY) LTD, (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Meloxicam Export Value and How Much Does Aurobindo Pharma Ltd Contribute?
India exported $62.9M worth of Meloxicam through 3,297 shipments from 277 suppliers to 100 countries, serving 566 buyers globally. Aurobindo Pharma Ltd contributes $1.1M to this total, accounting for 0.6% of India's Meloxicam exports. Aurobindo Pharma Ltd ships Meloxicam to 14 countries through 34 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Ltd's Meloxicam Exports?
Aurobindo Pharma Ltd's average Meloxicam shipment value is $8.4K per consignment, based on 127 shipments totaling $1.1M. The largest destination is TANZANIA (33.2% of Aurobindo Pharma Ltd's Meloxicam exports).
How Does Aurobindo Pharma Ltd Compare to Other Indian Meloxicam Exporters?
Aurobindo Pharma Ltd ranks #7 among 277 Indian Meloxicam exporters with a 0.6% market share. The top 3 exporters are CIPLA LIMITED ($28.7M), UNICHEM LABORATORIES LIMITED ($18.4M), ZYDUS LIFESCIENCES LIMITED ($6.2M). Aurobindo Pharma Ltd processed 127 shipments to 13 destination countries.
What Meloxicam Formulations Does Aurobindo Pharma Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MELOXICAM 7.5 MG TABLETS (Meloxicam Auro | $64.2K | 12 |
| MELOXICAM 7.5 MG TABLETS (100'S)(15936PAK)(AURO-MELOXICAM 7.5) | $62.6K | 2 |
| MELOXICAM TABLETS 15 MG(AURO-MELOXICAM 1 | $62.5K | 5 |
| MELOXICAM TABLETS 15 MG (AROXICAM 15) 10 | $50.0K | 1 |
| MELOXICAM TABLETS 15 MG (AROXICAM 15) 10X10'S (16190 Packs) | $50.0K | 1 |
| MELOXICAM TABLETS 15 MG AROXICAM 15 10X10 S QTY 13580 PAK | $43.6K | 1 |
| MELOXICAM TABLETS 15 MG (10X10'S)(6110PAK)(AROXICAM 15) | $39.8K | 2 |
| MELOXICAM 7.5 MG TABLETS(FLAMARYX 7.5 mg | $37.4K | 3 |
| MELOXICAM TABLETS 15 MG (100'S)(7920PAK)(AURO-MELOXICAM 15) | $36.4K | 2 |
| MELOXICAM TABLETS 15 MG (AROXICAM 15) 10X10'S (10360 Packs) | $35.1K | 1 |
Aurobindo Pharma Ltd exports 93 distinct Meloxicam formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MELOXICAM 7.5 MG TABLETS (Meloxicam Auro with 12 shipments worth $64.2K.
Regulatory Requirements: Exporting Meloxicam to Key Markets
What Aurobindo Pharma Ltd must comply with to export Meloxicam to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Ltd Compare to Nearest Meloxicam Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | ZYDUS LIFESCIENCES LIMITED | $6.2M | 184 | 4 | $33.7K |
| 4 | LUPIN LIMITED | $1.5M | 30 | 1 | $50.0K |
| 7 | AUROBINDO PHARMA LTD ★ | $1.1M | 127 | 13 | $8.4K |
| 8 | GRACURE PHARMACEUTICALS LIMITED | $1.0M | 40 | 1 | $26.0K |
| 9 | CADILA HEALTHCARE LIMITED | $1.0M | 30 | 3 | $33.3K |
Aurobindo Pharma Ltd ranks #7 among 277 Indian Meloxicam exporters. Average shipment value of $8.4K compared to the market average of $227.2K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and LUPIN LIMITED.
Which Indian Ports Ship Meloxicam Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 583 | 17.7% |
| JNPT/ NHAVA SHEVA SEA | 374 | 11.3% |
| SAHAR AIR | 370 | 11.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 276 | 8.4% |
| JNPT | 242 | 7.3% |
| NHAVA SHEVA | 147 | 4.5% |
| MUNDRA SEA | 137 | 4.2% |
| Bombay Air | 117 | 3.5% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Meloxicam — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Meloxicam shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 139 individual customs records matching Aurobindo Pharma Ltd exporting Meloxicam, covering 93 formulations to 14 countries via 34 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 566+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Meloxicam Export Data from Aurobindo Pharma Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Ltd's Meloxicam exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Meloxicam Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Meloxicam. For current shipment-level data, contact TransData Nexus.